Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
Prinz, J C
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. [electronic resource] - Journal of the European Academy of Dermatology and Venereology : JEADV May 2011 - 559-64 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1468-3083
10.1111/j.1468-3083.2010.03838.x doi
Adult
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
Dermatologic Agents--therapeutic use
Double-Blind Method
Drug Administration Schedule
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Male
Middle Aged
Psoriasis--drug therapy
Quality of Life
Receptors, Tumor Necrosis Factor--therapeutic use
Severity of Illness Index
Treatment Outcome
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. [electronic resource] - Journal of the European Academy of Dermatology and Venereology : JEADV May 2011 - 559-64 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
1468-3083
10.1111/j.1468-3083.2010.03838.x doi
Adult
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
Dermatologic Agents--therapeutic use
Double-Blind Method
Drug Administration Schedule
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Male
Middle Aged
Psoriasis--drug therapy
Quality of Life
Receptors, Tumor Necrosis Factor--therapeutic use
Severity of Illness Index
Treatment Outcome